19 May 2013
Keywords: boehringer, tipranavir, effective, resistant, hiv, ingelheim, germany
Article | 15 July 2002
Boehringer Ingelheim of Germany's non-peptidic HIV protease inhibitortipranavir has been shown to have efficacy when used as part of a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 July 2002
8 July 2002
17 May 2013
© 2013 thepharmaletter.com